Showing 6 posts of 6 posts found.

Axsome’s late-stage study of experimental depression drug misses main trial goal

March 31, 2020
Manufacturing and Production Depressive Disorder, MDD, depression, migraine

Axsome Therapeutics reported on Monday that its Phase 3 study of its experimental depression drug missed its main trial goal. …


European Commission authorises Janssen’s anti-depressant Spravato

December 23, 2019
Sales and Marketing Janssen, MDD, Nasal Spray, TRD, depression, mental health

The European Commission has approved Janssen’s nasal spray Spravato (esketamine), which is used to treat major depressive disorder (MDD) that …

Oral contraceptive use as teenager linked to depression as an adult, study says

August 29, 2019
Research and Development MDD, depression, hormones, oral contraceptives, psychiatry, psychology

Women who have used oral contraceptives as teenagers are more likely to experience depression later in life, according to a …


Minerva’s insomnia treatment beats Ambien in Phase 2b trial

June 25, 2019
Manufacturing and Production MDD, Minerva Neurosciences, Placebo, ambien, insomnia, pharma, zolpidem

Massachusetts-based firm Minerva Neurosciences has announced that its sleeping pill seltorexant beat both Sanofi’s Ambien (zolpidem) and placebo in treating …

Pfizer releases new data for Pristiq

May 9, 2012
Research and Development, Sales and Marketing Effexor, MDD, Pfizer, Pristiq, antidepressant

Pfizer has released positive data for its established antidepressant Pristiq, as it hopes to extend the use of the drug.  …

Targacept cuts workforce

May 1, 2012
Research and Development, Sales and Marketing AstraZeneca, MDD, TC-5214, Targecept

The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …

Latest content